Back to Statements & Guidelines

US FDA Safety Communication on Breast Implant Associated Squamous Cell Carcinoma (BIA-SCC)

The US Food and Drug Administration (FDA) recently posted a Safety Communication informing healthcare practitioners and patients about reports of squamous cell carcinoma (SCC) and various lymphomas (not including BIA-ALCL) detected in the capsule surrounding breast implants. These reports highlight a very rare occurrence of malignancy. We believe that developments such as this deserve attention so that you, your staff, and your patients may stay informed.

Read the full article below.

PDF Viewer